Immune Privilege, Müller cells, and Autophagy
免疫特权、Müller 细胞和自噬
基本信息
- 批准号:10501886
- 负责人:
- 金额:$ 43.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Anti-Inflammatory AgentsAutoimmune DiseasesAutophagocytosisBacteriaBiological ProcessBlindnessBlood-Retinal BarrierCell physiologyCellsCellular biologyDataDegradation PathwayDevelopmentDiseaseDisease modelEatingElementsEndotoxinsEyeEye diseasesFailureGenesHomeostasisImmuneImmune responseImmune systemInfectionInflammationInflammatoryInflammatory InfiltrateInflammatory ResponseKeratoplastyLeadLigandsMediatingMinorMitochondriaModelingMolecularMorphologyMuller&aposs cellMusNatureNeurogliaNeurotransmittersOrganParticipantPathogenicityPathway interactionsPhagocytesPhagocytosisPhotoreceptorsProcessProductionPropertyReceptor CellRecyclingResistanceRetinaRetinal DegenerationRetinal DiseasesRoleSiteStressSystemT cell responseT-Cell ReceptorTestingThickTissuesToll-like receptorsUveitisVirus DiseasesVisionVitamin Aantigen-specific T cellsarmautoimmune uveitisbasecell injurycytokineextracellularimmunoregulationneuroprotectionnovelnovel strategiespreventprotein aggregationresponseretinal damagesingle-cell RNA sequencingvirtualvisual cycle
项目摘要
Abstract
Immune privilege is a term applied to organs such as the eye that have a unique relationship with the
immune response. These sites prohibit the spread of inflammation since even minor episodes can threaten
vision. The breakdown of immune privilege is thought to have serious consequences for the eye; however, in
spite its powerful influence on inflammation we know little about how immune privilege influences retinal
diseases. Müller cells are the major glial cell of the retina that maintain structural integrity. They react in
virtually every eye disease but are strikingly resistant damage; importantly they can suppress inflammation.
Based on this they should be key participants in immune privilege, but this is not understood. The biological
process of autophagy (literally self-eating) is a recycling system that destroys inflammation-inducing cellular
debris to prevent tissue damage. Because immune privilege, Müller cells, and autophagy all have anti-
inflammatory properties, we will test the novel hypothesis that Müller glial cells utilize the autophagy pathway to
support the anti-inflammatory nature of the eye (i.e. immune privilege). We will do this by examining
intraocular inflammation in 2 well-characterized disease models, endotoxin induced uveitis (EIU) and
experimental autoimmune uveitis (EAU), utilizing mice with autophagy-deficient retinal Müller cells. Since EIU
is mediated by the innate arm of the immune system and EAU is an antigen specific T cell mediated disease
we will get thorough understanding as to how Müller cell autophagy influences different types of immune
mediated diseases of the eye. In Aim 1 we will assess the intraocular inflammatory response in these models
by comparing control mice with mice that have had the essential autophagy genes Atg5 and Fip200 deleted
specifically in Müller glial cells. We will evaluate inflammatory infiltrates, cytokine production, and retinal
integrity in both models. Preliminary data suggests that inflammation and retinal damage are enhanced in the
presence of autophagy deficient Müller cells in both models. In Aim 2 we will we will define the molecular basis
of these enhanced inflammatory response to determine the contribution of autophagy to immunoregulatory
properties of Müller cells in the eye. Studies will include scRNA-seq analysis, examination of the blood retinal
barrier, analysis of the T-cell response in EAU, and morphological analysis. In Aim 3 we will test the idea that
autophagy supports phagocytosis in Müller cells promoting their anti-inflammatory properties using the process
of LC3-associated phagocytosis (or LAP). We will test whether LAP recovers a portion of the vitamin A for the
Müller visual cycle. By elucidating the role of Müller cells and autophagy in immune privilege we will better
understand their influence on ocular inflammatory responses. Thus, rather than just treating inflammation, we
could consider upregulating immune privilege alone, or in combination with other treatments, to target retinal
disease.
摘要
免疫特免权是一个术语,适用于眼睛等与
免疫反应。这些网站阻止炎症的传播,因为即使是轻微的发作也可能威胁到
幻象。免疫特权的崩溃被认为对眼睛有严重的后果;然而,在
尽管免疫豁免对炎症有强大的影响,但我们对免疫豁免如何影响视网膜知之甚少
疾病。米勒细胞是视网膜中维持结构完整性的主要神经胶质细胞。他们的反应是
几乎所有的眼科疾病,但都是惊人的抵抗损害;重要的是,他们可以抑制炎症。
基于这一点,他们应该是免疫特权的关键参与者,但这一点还不被理解。生物学的
自噬过程(字面意思是自噬)是一种循环系统,它摧毁了引发炎症的细胞
碎片以防止组织损伤。因为免疫豁免、Müler细胞和自噬都有抗
炎症特性,我们将检验Müler神经胶质细胞利用自噬途径
支持眼睛的抗炎特性(即免疫特权)。我们将通过检查
两种典型疾病模型的眼内炎症:内毒素诱导性葡萄膜炎和
实验性自身免疫性葡萄膜炎(EAU),利用自噬缺陷的视网膜Müler细胞的小鼠。自EIU以来
是由免疫系统的先天手臂介导的,而EAU是一种抗原特异性T细胞介导的疾病
我们将彻底了解Müler细胞自噬如何影响不同类型的免疫
传播的眼部疾病。在目标1中,我们将评估这些模型的眼内炎症反应。
通过比较对照小鼠和缺失了必要的自噬基因ATG5和FIP200的小鼠
尤其是在Müler胶质细胞中。我们将评估炎症浸润物、细胞因子产生和视网膜
在两种模式中都是完整的。初步数据显示,炎症和视网膜损伤在
在两种模型中都存在自噬缺陷的Müler细胞。在目标2中,我们将定义分子基础
这些增强的炎症反应以确定自噬对免疫调节的贡献
眼内Müler细胞的特性。研究将包括scrna-seq分析,血视网膜检查。
屏障,分析EAU中的T细胞反应,以及形态分析。在目标3中,我们将测试这样的想法
自噬支持Müler细胞的吞噬作用,通过该过程促进其抗炎特性
与LC3相关的吞噬作用(或LAP)。我们将测试LAP是否能回收一部分维生素A
米勒视觉循环。通过阐明Müler细胞和自噬在免疫豁免中的作用,我们将更好地
了解它们对眼部炎症反应的影响。因此,我们不仅治疗炎症,还
可以考虑单独上调免疫特免权,或与其他治疗方法联合使用,以针对视网膜
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas Almon Ferguson其他文献
Thomas Almon Ferguson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas Almon Ferguson', 18)}}的其他基金
Modulation of cone photoreceptor function by autophagy
自噬调节视锥光感受器功能
- 批准号:
10681018 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Immune Privilege, Müller cells, and Autophagy
免疫特权、Müller 细胞和自噬
- 批准号:
10680566 - 财政年份:2022
- 资助金额:
$ 43.18万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别: